Otros idiomas Janux Therapeutics, Inc.

Acciones

JANX

US47103J1051

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
62,43 ^USD	+7,29 %		+32,55 %	+481,83 %

16/04	JANUX THERAPEUTICS, INC. : Obtiene una recomendación de compra de JonesTrading Institutional Services	ZM
10/04	Actualización del sector: Los valores del sector sanitario caen a última hora de la tarde	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Aktien New York: Dow erholt sich vor Start in die Berichtssaison	11/04
Aktien New York: Dow schwächer vor Start in die Berichtssaison	11/04
Aktien New York Ausblick: Vor dem Start in die Berichtssaison stabil erwartet	11/04
Sector Update: Health Care Stocks Slipping Late Afternoon	10/04
Sector Update: Health Care	10/04
Janux Therapeutics Said to be Considering Sale	10/04
Janux Therapeutics Considering Options, Including Sale, Bloomberg Reports	10/04
Janux Therapeutics Q4 Net Loss Narrows, Revenue Decreases	08/03
Janux Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Janux Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	08/03
Janux Therapeutics Prices $296.5 Million Offering of Common Stock, Pre-Funded Warrants	29/02
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants	29/02
Janux Therapeutics Announces Proposed Public Offering of Common Stock	27/02
Sector Update: Health Care Stocks Ease Late Afternoon	27/02
Sector Update: Health Care	27/02
Aktien New York: Börsen bleiben nahe Rekordhochs	27/02
Top Midday Gainers	27/02
Janux Therapeutics Shares Soar After Wedbush Boosts Price Target Following 'Positive' Data From Two Cancer Studies	27/02
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Data for Rate-Cut Hints	27/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Janux Therapeutics, Inc.

Acciones

JANX

US47103J1051

Otros idiomas

Filtros